Skip to main content
Log in

First-in-Men Treatment of Carotid Artery In-Stent Restenosis with a Novel Sirolimus-Eluting Balloon Technology

  • Letter To The Editor
  • Arterial Interventions
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Huang H, Wu L, Goo Y, Zhang Y, Zhao J, Yu Z, Luo X. Treatment of the carotid in-stent restenosis: a systematic review. Front Neurol. 2021;12: 748304.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bhatia K, Akhtar IN, Akinci Y, Liaqat J, Siddiq F, Gomez CR, Qureshi AI. Drug-eluting balloon angioplasty for in-stent restenosis following carotid artery stent placement. J Neuroimaging. 2020;30(3):267–75.

    Article  PubMed  Google Scholar 

  3. Abizaid A. Sirolimus-eluting coronary stents: a review. Vasc Health Risk Manag. 2007;3(2):191–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Zeller T, Brechtel K, Meyer DR, Noory E, Beschorner U, Albrecht T. Six-month outcomes from the first-in-human, single-arm SELUTION sustained-limus-release drug-eluting balloon trial in femoropopliteal lesions. J Endovasc Ther. 2020;27(5):683–90.

    Article  PubMed  Google Scholar 

  5. Liu Y, Yang F, Zou S, Qu L. Rapamycin: a bacteria-derived immunosuppressant that has anti-atherosclerotic effects and its clinical application. Front Pharmacol. 2019;7(9):1520.

    Article  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silke Hopf-Jensen.

Ethics declarations

Conflict of interest

All authors declare that this research was conducted in the absence of any commercial or financial conflict of interest.

Ethical Approval

For this type of retrospective study, formal consent is not required.

Consent for Publication

Consent for publication was obtained for every individual person’s data included in this study.

Informed Consent

Informed consent was obtained from all individuals participate included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hopf-Jensen, S., Müller-Hülsbeck, S. First-in-Men Treatment of Carotid Artery In-Stent Restenosis with a Novel Sirolimus-Eluting Balloon Technology. Cardiovasc Intervent Radiol 46, 819–820 (2023). https://doi.org/10.1007/s00270-023-03408-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-023-03408-y

Navigation